Congenital infantile fibrosarcoma: a masquerader of ulcerated hemangioma

Albert C Yan1, Sarah L Chamlin, Marilyn G Liang

  • 1Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. yana@email.chop.edu

Pediatric Dermatology
|August 22, 2006
PubMed

Insights

Congenital infantile fibrosarcoma is a rare childhood cancer that can mimic hemangiomas. Early diagnosis is crucial for managing this vascularized tumor, especially when ulcerated, to prevent severe bleeding and blood count issues.

Area of Science:

  • Pediatric Oncology
  • Dermatology
  • Surgical Pathology

Background:

  • Congenital infantile fibrosarcoma (CIF) is a rare malignant tumor affecting infants.
  • CIF can present as a highly vascularized mass, clinically resembling infantile hemangioma.
  • Ulceration of CIF can lead to severe complications like hemorrhage, anemia, and thrombocytopenia.

Observation:

  • This report details three cases of infants with ulcerated congenital infantile fibrosarcomas of the hand.
  • Clinical presentation of these lesions can be misleading, mimicking benign vascular tumors.
  • The potential for significant bleeding and associated hematologic abnormalities was noted.

Findings:

  • Congenital infantile fibrosarcomas, particularly when ulcerated, pose a diagnostic challenge due to their vascularity and resemblance to hemangiomas.
  • Ulcerated CIF in infants can result in substantial hemorrhage, leading to anemia and thrombocytopenia.
  • Timely and accurate diagnosis is essential for effective management.

Implications:

  • Distinguishing congenital infantile fibrosarcoma from hemangioma is critical for appropriate treatment planning.
  • Awareness of the clinical manifestations of ulcerated CIF can guide prompt diagnosis and intervention.
  • Improved diagnostic strategies are needed to ensure optimal outcomes for affected children.